GlassScriptPhysician profile
Kristi Roybal
NPI 1790160679
$2,217.20
in general payments reported to CMS, 2019-2025
33 companies · $732 in 2025
The $732 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $317 · 2023: $456 · 2024: $523 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,710.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $234.55 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $176.54 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Bayer Healthcare Pharmaceuticals INC. | $164.21 | 2022-2025 | |
| Abbvie INC. | $152.55 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $146.90 | 2022-2025 | Farxiga, Airsupra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $122.96 | 2023-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.69 | 2023-2025 | Jardiance |
| Lilly USA, LLC | $93.33 | 2022-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $92.20 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Viiv Healthcare Company | $89.98 | 2025 | Dovato |
| Alexion Pharmaceuticals, INC. | $82.97 | 2021-2022 | |
| Abbott Laboratories | $75.83 | 2021-2023 | Freestyle Libre 3 |
| Amgen INC. | $73.82 | 2022-2025 | Evenity, Prolia |
| Eisai INC. | $68.94 | 2022-2024 | |
| Lundbeck LLC | $61.91 | 2023-2024 | Rexulti |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $58.66 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.36 | 2023-2025 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $39.54 | 2024 | Xarelto |
| Globus Medical, INC. | $38.53 | 2021 | |
| Allergan, INC. | $31.50 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $29.83 | 2024 | Rexulti |
| Sumitomo Pharma America, INC. | $24.70 | 2023-2025 | Gemtesa |
| Aimmune Therapeutics, INC. | $22.52 | 2024 | |
| Gilead Sciences, INC. | $22.17 | 2024 | |
| Xeris Pharmaceuticals, INC. | $21.16 | 2023 | Gvoke Hypopen |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $20.73 | 2025 | |
| Cequr Corporation | $20.01 | 2023-2024 | Cequr Simplicity |
| Astellas Pharma US INC | $19.34 | 2024 | Veozah |
| Nestle Healthcare Nutrition INC. | $16.35 | 2023 | |
| Alfasigma USA, INC. | $15.58 | 2022 | |
| Boston Scientific Corporation | $15.15 | 2025 | Watchman Access System |
| Merck Sharp & Dohme LLC | $14.08 | 2022 | |
| Corium, LLC | $6.61 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristi Roybal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.